Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bionik Laboratories Corp (BNKL)

Bionik Laboratories Corp (BNKL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bionik Laboratories Corp 80 COOLIDGE HILL ROAD WATERTOWN MA 02472 USA

www.bioniklabs.com P: 617-926-4800

Description:

Bionik Laboratories Corp. is a medical device and robotics company which focuses in developing transformational technologies and solutions for individuals with neurological disorders. The company offers ARKE, a lower body exoskeleton for wheelchair bound individuals suffering from spinal cord injuries, strokes and other mobility disabilities to restore gait and walk again during the rehabilitation process. It also provides Cronos and the Apollo research programs. Chronos system is a patient queuing system for clinics and hospitals; Apollo is an above-the-knee prosthetic device. Bionik Laboratories Corp. is headquartered in Toronto, Canada.

Key Statistics

Overview:

Market Capitalization, $K 1,248
Enterprise Value, $K 818
Shares Outstanding, K 12,480
Annual Sales, $ 1,810 K
Annual Net Income, $ -4,950 K
Last Quarter Sales, $ 500 K
Last Quarter Net Income, $ -1,360 K
EBIT, $ -4,820 K
EBITDA, $ -4,760 K
60-Month Beta -1.22
% of Insider Shareholders 40.37%
% of Institutional Shareholders 0.00%
Float, K 7,442
% Float 59.63%
Short Volume Ratio 0.30

Growth:

1-Year Return -66.89%
3-Year Return -96.87%
5-Year Return -99.77%
5-Year Revenue Growth 82.83%
5-Year Earnings Growth 97.18%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.08 on 06/21/23
Latest Earnings Date 06/19/24
Earnings Per Share ttm -0.58
EPS Growth vs. Prev Qtr 53.33%
EPS Growth vs. Prev Year 75.86%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-150 on 10/30/18

BNKL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -273.48%
Debt/Equity -1.31
Price/Sales 0.22
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.24
Interest Coverage -44.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar